Biotech startup NantHealth launched into the market Thursday after its initial public offering, with the stock surging nearly 33 percent. » Read More
Scientists are one step closer in harnessing the power of genome sequencing to help improve the diagnosis and treatment of autism.
The Swiss pharmaceutical company struggles after a cheaper version of Gleevec launched in February.
With a grant from the Defense Department, a Florida medical center is creating a video game to train doctors for robotic surgery.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
It's hoped the FDA will approve an artificial pancreas in 2017. The device is expected to transform treatment of type 1 diabetes.
March 23- Respironics Inc has agreed to pay $34.8 million to settle U.S. Department of Justice claims that it provided kickbacks in the form of free call center services to suppliers, to induce them to buy its masks for patients suffering from sleep apnea. Gibran Ameer, a South Carolina pharmacist who worked for medical equipment suppliers that bought the masks.
Bill Ackman should have listened!
The Zika virus is prompting bug spray manufacturer S.C. Johnson to ramp up production, reports CNBC's Mary Thompson.
Feb 16- Medical device maker Stryker Corp said it would buy Physio-Control International Inc for $1.28 billion in cash to expand its emergency medical services business and raised its full-year earnings forecast for the second time this month. The company earlier this month inked a deal with medical supplies maker Sage Products LLC for $2.78 billion and...
New advances provide new hope for prosthetics, including an accurate sense of touch and robotic limbs developed at a fraction of the cost.
Before testing your own genome, it helps to realize it can raise more questions than it answers.
A $199 service from health company 23andMe gives individuals data from ancestry to risks of carrying a genetic condition.
Personalized medicine is more costly than traditional treatment, which worries insurers. But these drugs can improve outcomes for patients.
About 1 in 5 Medicare dollars is spent on this disease that affects over 5 million Americans. Yet not enough is being done to find a cure.
Elton John told CNBC that he could petition the queen to force Commonwealth countries to revoke anti-gay legislation.
Bone replacements, human tissue and prosthetics are being created by 3-D bioprinters. The science will soon be used to customize drugs.
Theranos only uses its finger-prick technology in one test after pressure from regulators, The WSJ reports.
As baby boomers age, UPS, FedEx and DHL expect health-care logistics to become a more important part of their future.
China's much-hyped market for vitamins and supplements is facing a steep challenge from traditional remedies from ginseng to deer antler.
Teen creates cheaper way to test for Ebola